<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00425178</url>
  </required_header>
  <id_info>
    <org_study_id>CVBT-W2005-01</org_study_id>
    <nct_id>NCT00425178</nct_id>
  </id_info>
  <brief_title>FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers</brief_title>
  <official_title>A Phase 1, Open Label, Single Dose, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Patients With Diabetic or Venous Stasis Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CardioVascular BioTherapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CardioVascular BioTherapeutics, Inc.</source>
  <brief_summary>
    <textblock>
      FGF-1 is being used for the treatment of patients with diabetic or venous stasis ulcers.
      Procedure includes topical administration of FGF-1 or placebo and evaluation of safety,
      pharmacokinetics, and wound improvement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients meeting eligibility criteria will be randomized to receive topical administration of
      either FGF-1 or placebo. Patients will be evaluated at days 1 and 7, post-treatment for
      safety, pharmacokinetics, and wound healing.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Pharmacokinetics</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound improvement</measure>
  </secondary_outcome>
  <enrollment type="Actual">8</enrollment>
  <condition>Chronic Wounds</condition>
  <condition>Diabetes</condition>
  <condition>Venous Stasis Ulcers</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>FGF-1</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Eligibility Criteria:

          -  Informed consent

          -  Female patients post-menopausal, sterilized, or on adequate birth control

          -  Full-thickness lower extremity diabetic or venous statis ulcers of specific target
             size and of at least 8 weeks but no more than 1 year duration

          -  Target ulcer freshly debrided at screening or within two weeks prior to screening

          -  Adequate blood supply defined by transcutaneous oxygen pressure &gt; 20 mmHG and ABI
             greater than or equal to 0.4

          -  Compliance with non-weight bearing regimen in diabetic patients

          -  Compliance with wound care regimen
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas E Serena, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Warren General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Warren General Hospital</name>
      <address>
        <city>Warren</city>
        <state>Pennsylvania</state>
        <zip>16365</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2007</study_first_submitted>
  <study_first_submitted_qc>January 18, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2007</study_first_posted>
  <last_update_submitted>January 7, 2008</last_update_submitted>
  <last_update_submitted_qc>January 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2008</last_update_posted>
  <keyword>Chronic wounds</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Ulcers</keyword>
  <keyword>Arterial bypass</keyword>
  <keyword>Angioplasty</keyword>
  <keyword>Diabetic ulcers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Postphlebitic Syndrome</mesh_term>
    <mesh_term>Postthrombotic Syndrome</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

